key: cord-1034094-ejsoya28 authors: Fujimoto, K.; Ishimaru, T.; Tateishi, S.; Nagata, T.; Tsuji, M.; Eguchi, H.; Ogami, A.; Matsuda, S.; Fujino, Y. title: A cross-sectional study of socioeconomic status and treatment interruption among Japanese workers during the COVID-19 pandemic date: 2021-02-23 journal: nan DOI: 10.1101/2021.02.22.21252190 sha: 4ab9500760a5118e6b8ed5daa913a50ace5b556f doc_id: 1034094 cord_uid: ejsoya28 Background: The COVID-19 pandemic has caused interruptions to chronic disease and non-emergency treatment. The purpose of this study is to examine which socioeconomic status groups are most at risk of treatment interruption. Methods: This cross-sectional internet monitor study was conducted on December 22-26, 2020, when Japan experienced its third wave of COVID-19 infection. Out of a total of 33,302 participants in the survey, 9510 (5392 males and 4118 females) who responded that they required regular treatment or hospital visits were included in the analysis. A multilevel logistic model nested in the prefecture of residence was used to estimate the odds ratio (OR) for treatment disruption. We examined separate multivariate models for socioeconomic factors, health factors, and lifestyle factors. Results: During a period of rapid COVID-19 infection, about 11% of Japanese workers who required regular treatment experienced interruptions to their treatment. The OR of treatment interruption associated with not being married compared to being married was 1.44; manual labor work compared to desk work was 1.30; loss of employment when the COVID-19 pandemic started and continued unemployment compared to being employed over the entire pandemic period was 1.62 and 2.57, respectively; and feeling financially unstable was 2.92. Conclusion: Treatment interruption is a new health inequality brought about by COVID-19 with possible medium- and long-term effects, including excess mortality, morbidity, and productivity loss due to increased presenteeism. Efforts are needed to reduce treatment interruptions among workers who require regular treatment. Soon after COVID-19 was first confirmed in China, it quickly spread around the 62 world. In January 2020, health authorities confirmed that the infection had spread to Japan. 63 Subsequently, the country experienced peaks of infection in May and August 2020, which 64 lasted for relatively short periods of time. The number of infected people and deaths were 65 considered low compared to that in other countries. However, in November 2020, the number 66 of infections rose again, and in December, Japan was experiencing its third wave of infection. 67 This time, a larger number of people were becoming infected compared to the previous two 68 waves. The hospital bed occupancy rate was high, and medical treatment was being affected. 69 In January 2021, the Japanese government declared a second state of emergency for 11 70 prefectures. The COVID-19 pandemic has caused interruptions to chronic disease and non-72 emergency treatment around the world 1-5 . In the United States, 40% of adults are reportedly 73 avoiding medical care 1 . According to a survey of 47 countries, only 14% of responding health 74 care providers continued to provide normal face-to-face care 2 . In Japan, the number of 75 prescriptions in May 2020 made up just 75% of the prescriptions given out one year prior in 76 May 2019 3 . In pediatrics and otolaryngology, the number of prescriptions halved 3 . 77 There are several reasons why treatment may be being interrupted during the COVID-78 19 pandemic. Because hospitals are perceived as high-risk places for infection, patients may 79 be voluntarily abstaining from treatment because they are concerned about becoming infected 80 in the hospital 1 . In addition, many medical institutions are rescheduling visits with non-81 emergency patients to enable them to deal with COVID-19 and to set up fever outpatient 82 clinics 6,7 . It is also likely that the financial impact of COVID-19 is causing patients to 83 discontinue treatment, given that financial difficulties generally lead to interruption of 84 treatment for chronic diseases 8-10 . 85 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252190 doi: medRxiv preprint Delay or avoidance of medical care may increase excess mortality directly or 86 indirectly related to COVID-19 1 . Delays and avoidance of treatment can lead to worse 87 management of chronic diseases, missed opportunities for regular checkups, and missed or 88 delayed initiation of treatment for deteriorating health conditions. This results in an increase 89 of morbidity and mortality from health conditions that are otherwise treatable or 90 preventable 4,11,12 . 91 Furthermore, interruptions to treatment among workers increase presenteeism 13 , a 92 practice in which individuals continue to work while unwell. Continued presenteeism can 93 lead to lower productivity, further deterioration of health status, and even difficulties with 94 staying in the labor market 14 . Anxieties related to possible infection after seeking medical 95 care and the need to reschedule regular medical appointments due to the COVID-19 96 pandemic are causing interruptions to medical treatment for workers. In addition, economic 97 insecurity and job insecurity are causing workers to feel that they need to make their presence 98 known to management, which can discourage workers from actively taking sick leave. While treatment interruptions are increasing in Japan due to the COVID-19 100 pandemic 3 , it is unclear which groups of individuals are most at risk. COVID-19 is having a 101 significant impact on the socioeconomic status of workers, and such changes are expected to 102 affect the consultation behavior of workers with chronic diseases. Therefore, the purpose of 103 this study is to examine which socioeconomic status groups are most at risk of treatment 104 interruption. All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in We used the following single-item question to examine the participants' treatment 119 status: "Do you have any disease that requires regular visits to the hospital or treatment?" Respondents were asked to select from the following options: "I do not have such a disease;" 121 "I am continuing with hospital visits and treatment as scheduled;" "I am not able to continue 122 with hospital visits and treatment as scheduled." perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252190 doi: medRxiv preprint unemployed for a period, but currently working; retired and started a business), and 132 perception of financial situation (very difficult, slightly difficult, fairly difficult, comfortable). Health and psychological factors included self-rated health, psychological distress, 134 feeling alone, having a friend who can provide support, and having a health condition that 135 requires company support to enable work. Psychological distress was assessed using Kessler 136 6 (K6) 16 , the validity of the Japanese version of which has been confirmed 17 . In the present 137 study, a K6 score of 5 or higher was used as the cutoff for mild psychological distress. The 138 following question was used to examine loneliness: "Have you ever felt alone?" Subjects 139 chose from the following options: "never," "a little," "sometimes," "usually," "always." Subjects were asked the following questions to determine if they had a health condition that 141 required company support to enable work: "Do you require consideration or support from 142 your company to continue working in your current health condition?" Subjects chose from 143 the following three options: "no;" "yes, but I have not received support;" "yes, and I have 144 received support." The following lifestyle and work-related factors were examined: smoking (never; quit 146 smoking more than one year ago; quit smoking within the past year; started smoking less than 147 one year ago; smoking for more than one year), alcohol consumption (6-7 days a week; 4-5 148 days a week; 2-3 days a week; less than 1 day a week; hardly ever), exercise habit, breakfast perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in self-rated health, psychological distress, feeling alone, presence of a friend who can provide 162 support, and presence of a health condition that requires company support to enable work. For lifestyle-related factors and work-related factors, the multivariate model was adjusted for 164 age, sex, smoking, alcohol consumption, exercise habit, breakfast routine, time spent on one-165 way commute and overtime work hours per day. All analyses used the incidence rate of 166 COVID-19 by prefecture as a prefecture-level variable. A p value less than .05 was considered statistically significant. All analyses were perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Table 1 shows the basic characteristics of the survey subjects. Of the 9510 subjects 172 who required regular treatment, 11% discontinued treatment. Those who were continuing 173 treatment reported better self-rated health than those who had discontinued treatment. Those 174 who had experienced treatment interruption were more likely to experience psychological 175 distress (77%), feel alone (30.8%), and skip breakfast. Those who had interrupted treatment 176 also worked more overtime hours. 177 Table 2 shows the association between socioeconomic status and treatment Table 3 shows the association between health status, psychological distress and 186 treatment interruption. Multivariate analysis showed that the OR of treatment interruption 187 associated with poor self-rated health was 5.27; experiencing psychological distress was 3.78; 188 always feeling alone was 5.45; having no friends who can provide support was 2.13; and 189 requiring company consideration to enable work but not receiving it was 5.87. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252190 doi: medRxiv preprint 1.32; rarely eating breakfast was 2.28; a one-way commute of more than 2 hours was 1. 86; 196 and working more than 2 hours of overtime in an average day was 3.17. 197 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in In the present study, we showed that workers with poorer health status were more 218 likely to experience treatment interruption: those with poorer self-rated health, psychological 219 distress, loneliness, and workplace support were more likely to experience treatment 220 interruption. The causal relationship between health status and treatment interruption may 221 also be bi-directional. Several studies have reported that a major reason for treatment 222 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in interruption is anxiety related to becoming infected when visiting a hospital 1,2,4 . In the present 223 study, greater psychological distress was associated with higher odds of discontinuing 224 treatment, suggesting that anxiety about infection may influence treatment discontinuation. In 225 addition, subjects who did not receive company support were more likely to discontinue 226 treatment. This may be because company support includes adjustment of an individual's 227 work hours for treatment and encouragement from management for the worker to see a doctor. Loneliness may also be related to whether or not a work colleague is able to accompany the were more likely to experience treatment interruption. It is therefore paramount that we 245 prepare for the possibility that COVID-19 may not only threaten as an acute infectious 246 disease, but also by affecting the prognosis and complications of those with chronic and 247 All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in such campaigns. In this study, we found that workers with unfavorable lifestyle habits were 251 more likely to experience treatment interruption. Therefore, a strategy to ensure that outreach 252 messages are delivered efficiently is needed, especially to populations with low health 253 literacy. Telemedicine is a promising method by which to handle treatment interruptions 254 arising due to infection-related anxiety 25 . Extending the length of prescriptions is also a good 255 approach. However, the safety of these approaches must be monitored, given that there are 256 now fewer opportunities to observe patients' health status. Our findings also demonstrate the 257 importance of proactive support by companies to facilitate the delivery of treatment to sick 258 workers. Such support is expected to reduce presenteeism and improve labor productivity. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The authors declare no conflicts of interest associated with this manuscript. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in Table 3 . Association between health status, psychological distress and treatment interruption. * The multivariate model was adjusted for age, sex, self-rated health, psychological distress, feeling alone, presence of a friend who can provide support, and presence of a health condition that requires company support to enable work. Age-sex adjusted Multivariate* 95%CI 95%CI All rights reserved. No reuse allowed without permission. perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in The copyright holder for this this version posted February 23, 2021. ; https://doi.org/10.1101/2021.02.22.21252190 doi: medRxiv preprint Socioeconomic Status and Access to 321 Healthcare: Interrelated Drivers for Healthy Aging. Front Public Health Sociodemographic 323 inequalities in patients' experiences of primary care: an analysis of the All-Cause Excess Mortality Related Mortality Among US Adults Aged 25-44 Years Presenteeism during the COVID-19 pandemic: risks and solutions Prospective Cohort Study of Work Functioning 335 Impairment and Subsequent Absenteeism Among Japanese Workers